Ligand Pharmaceuticals Inc. (LGND) is a publicly traded Healthcare sector company. As of October 27, 2026, LGND trades at $311.82 with a market cap of $6.15B and a P/E ratio of 28.86. LGND moved +1.44% today. Year to date, LGND is +63.97%; over the trailing twelve months it is +64.09%. Its 52-week range spans $93.58 to $326.63. Analyst consensus is strong buy with an average price target of $362.83. Rallies surfaces LGND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LGND, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $311.82 |
| Market Cap | $6.15B |
| P/E Ratio | 28.86 |
| EPS | $10.07 |
| Dividend Yield | 0.08% |
| 52-Week High | $326.63 |
| 52-Week Low | $93.58 |
| Volume | 105.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $290.54M |
| Net Income | $197.22M |
| Gross Margin | 0.00% |
8 analysts cover LGND: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $362.83.